{
    "nct_id": "NCT06132685",
    "official_title": "Post-Operative Dosing of Steroids Post Craniotomy for Brain Tumor (PODS)",
    "inclusion_criteria": "* Patients with radiographic findings consistent with either HGG, LGG, Meningioma, or brain metastasis\n* Age equal to or above 18\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Known hypothalamic-pituitary-adrenal (HPA) axis dysfunction\n* Tumor causing compression of the sella or pituitary dysfunction\n* Known immunodeficiency - including but not limited to severe combined immunodeficiency (SCID), common variable immunodeficiency (CVID), lymphocytopenia\n* Taking immunosuppressive drugs - including but not limited to methotrexate, mycophenolate, rapamycin, tacrolimus, adalimumab, infliximab. Greater than two weeks of recent daily corticosteroid use or the use of corticosteroids equivalent to > 85 mg of dexamethasone in the last month\n* Current lymphoma or leukemia\n* History of solid organ transplant\n* Minors < 18\n* Pregnant women\n* History of cerebrovascular accident leading to neurologic deficit",
    "miscellaneous_criteria": ""
}